A detailed history of Two Sigma Investments, LP transactions in Arvinas, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 386,269 shares of ARVN stock, worth $9.99 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
386,269
Previous 178,326 116.61%
Holding current value
$9.99 Million
Previous $4.75 Million 100.4%
% of portfolio
0.02%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.66 - $32.73 $4.92 Million - $6.81 Million
207,943 Added 116.61%
386,269 $9.51 Million
Q2 2024

Aug 14, 2024

BUY
$24.46 - $40.4 $1.77 Million - $2.93 Million
72,407 Added 68.36%
178,326 $4.75 Million
Q1 2024

May 15, 2024

BUY
$36.38 - $52.31 $3.85 Million - $5.54 Million
105,919 New
105,919 $4.37 Million
Q3 2023

Nov 14, 2023

SELL
$19.64 - $28.21 $2.51 Million - $3.61 Million
-127,825 Reduced 78.52%
34,964 $686,000
Q2 2023

Aug 14, 2023

BUY
$21.73 - $31.43 $431,362 - $623,916
19,851 Added 13.89%
162,789 $4.04 Million
Q1 2023

May 15, 2023

BUY
$26.15 - $37.26 $3.74 Million - $5.33 Million
142,938 New
142,938 $3.91 Million
Q3 2022

Nov 14, 2022

BUY
$41.87 - $57.99 $1.18 Million - $1.63 Million
28,135 New
28,135 $1.25 Million
Q1 2022

May 16, 2022

SELL
$60.27 - $81.57 $2.7 Million - $3.66 Million
-44,813 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$65.85 - $96.21 $12.8 Million - $18.7 Million
-194,819 Reduced 81.3%
44,813 $3.68 Million
Q3 2021

Nov 15, 2021

SELL
$73.2 - $107.87 $2.22 Million - $3.28 Million
-30,370 Reduced 11.25%
239,632 $19.7 Million
Q2 2021

Aug 16, 2021

BUY
$60.45 - $84.26 $5.07 Million - $7.07 Million
83,885 Added 45.07%
270,002 $20.8 Million
Q1 2021

May 17, 2021

BUY
$58.19 - $91.37 $10.8 Million - $17 Million
186,117 New
186,117 $12.3 Million
Q4 2020

Feb 16, 2021

SELL
$20.19 - $84.93 $6.19 Million - $26 Million
-306,648 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$22.99 - $36.34 $1.92 Million - $3.04 Million
83,697 Added 37.54%
306,648 $7.24 Million
Q2 2020

Aug 14, 2020

BUY
$29.88 - $56.74 $4.37 Million - $8.3 Million
146,210 Added 190.52%
222,951 $7.48 Million
Q1 2020

May 15, 2020

BUY
$33.0 - $54.5 $32,406 - $53,519
982 Added 1.3%
76,741 $3.09 Million
Q4 2019

Feb 14, 2020

BUY
$15.39 - $44.38 $858,608 - $2.48 Million
55,790 Added 279.38%
75,759 $3.11 Million
Q3 2019

Nov 14, 2019

BUY
$21.55 - $27.61 $430,331 - $551,344
19,969 New
19,969 $430,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.38B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.